ACM
NUVB icon

ACT Capital Management’s Nuvation Bio NUVB Stock Holding History

ACT Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.95M Buy
520,000
+230,000
+79% +$1.12M 1.93% 15
2026
Q1 		$1.24M Sell
290,000
-320,500
-52% -$1.79M 0.98% 17
2025
Q4 		$5.47M Buy
+610,500
New +$3.78M 4.42% 9

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

ACT Capital Management's NUVB Position: Q2 2026 in Review

ACT Capital Management increased its Nuvation Bio (NUVB) stake by 79% in Q2 2026, buying an estimated $1.12M and bringing the position to 520,000 shares worth $2.95M. The position accounts for 1.93% of the portfolio, ranked #15.

ACT Capital Management first reported a position in NUVB in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.47M in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • ACT Capital Management held 520,000 shares of Nuvation Bio worth $2.95M as of Q2 2026.
  • ACT Capital Management bought 230,000 Nuvation Bio shares in Q2 2026, an estimated $1.12M.
  • Nuvation Bio made up 1.93% of ACT Capital Management's portfolio in Q2 2026, its #15 holding.
  • ACT Capital Management first reported a position in Nuvation Bio in Q4 2025 and has held it in 3 quarters since.
  • ACT Capital Management's Nuvation Bio position peaked at $5.47M in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on ACT Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.